Global Pharmaceutical Secondary Packaging Market Insights, Size, and Forecast By Packaging Type (Boxes, Labels, Blisters, Cartons, Clamshells), By Automation Level (Manual, Semi-Automatic, Fully Automatic), By End Use (Pharmaceuticals, Biopharmaceuticals, Nutraceuticals, Medical Devices), By Material Type (Plastic, Paperboard, Glass, Metal, Composite), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035
Key Market Insights
Global Pharmaceutical Secondary Packaging Market is projected to grow from USD 48.7 Billion in 2025 to USD 85.3 Billion by 2035, reflecting a compound annual growth rate of 6.2% from 2026 through 2035. This market encompasses the outer protective layers surrounding primary pharmaceutical packaging, providing crucial functions such as product protection, identification, patient information, and brand presentation. Key drivers propelling this growth include the escalating demand for biologics and specialized drugs requiring stringent protection, the expanding global pharmaceutical industry driven by an aging population and increasing chronic disease prevalence, and the growing emphasis on patient safety and traceability mandated by evolving regulatory frameworks worldwide. Furthermore, the rising adoption of sustainable packaging solutions and the need for enhanced anti-counterfeiting measures are significant contributors. The market is also witnessing a shift towards smart packaging solutions integrating features like serialization and tamper-evident designs, driven by stricter regulations for product authentication and supply chain integrity.
Global Pharmaceutical Secondary Packaging Market Value (USD Billion) Analysis, 2025-2035
2025 - 2035
www.makdatainsights.com
Important trends shaping the market include the increasing preference for sustainable and eco-friendly materials, pushing manufacturers to innovate with recyclable, biodegradable, and lightweight options. Personalization and customization of secondary packaging are also gaining traction, particularly for over-the-counter (OTC) products and specialty pharmaceuticals. The integration of advanced automation and robotics in packaging lines is optimizing efficiency and reducing human error. However, market growth faces restraints such as the fluctuating costs of raw materials, particularly paperboard and plastics, and the complexity of complying with diverse and stringent global packaging regulations, which can create barriers for market entry and product innovation. Nevertheless, the market presents significant opportunities through the development of innovative packaging formats for orphan drugs and personalized medicine, expansion into emerging markets with rapidly developing healthcare infrastructure, and strategic collaborations among packaging providers, pharmaceutical companies, and technology developers to create integrated, intelligent packaging solutions.
North America currently dominates the pharmaceutical secondary packaging market, driven by its well-established pharmaceutical industry, significant R&D investments, and stringent regulatory environment emphasizing product safety and integrity. The region’s early adoption of advanced packaging technologies and a high concentration of key pharmaceutical manufacturers contribute to its leading position. Conversely, Asia Pacific is identified as the fastest growing region, fueled by rapid economic development, expanding healthcare access, increasing pharmaceutical production capabilities, and a growing patient pool. The rising disposable income and improving healthcare infrastructure in countries within this region are stimulating demand for packaged pharmaceuticals. Among the various segments, cartons hold the largest share due to their versatility, cost-effectiveness, printability for information dissemination, and ability to provide robust product protection. Key players like Berry Global, International Paper, Crown Holdings, DS Smith, Schott, Neenah, Amcor, Gerresheimer, AptarGroup, and WestRock are strategically focusing on mergers and acquisitions, product innovation, and geographical expansion to strengthen their market positions and cater to the evolving needs of the global pharmaceutical industry.
Quick Stats
Market Size (2025):
USD 48.7 BillionProjected Market Size (2035):
USD 85.3 BillionLeading Segment:
Cartons (42.5% Share)Dominant Region (2025):
North America (35.8% Share)CAGR (2026-2035):
6.2%
Global Pharmaceutical Secondary Packaging Market Emerging Trends and Insights
Smart Packaging for Enhanced Patient Safety
Smart packaging is revolutionizing patient safety in pharmaceuticals by integrating intelligent features. This innovation includes technologies like NFC and RFID tags, enabling real time authentication and tracking of medications from production to consumption. Temperature sensitive drugs benefit from advanced indicators that alert both pharmacists and patients to potential spoilage, preventing the administration of compromised medication. Furthermore, digital dose counters and compliance monitors help patients adhere to prescribed regimens, reducing medication errors and improving therapeutic outcomes. Anti tampering seals and serialization features deter counterfeiting and ensure product integrity. These smart solutions provide unprecedented transparency and control throughout the supply chain, significantly enhancing patient confidence and safeguarding their health by ensuring they receive authentic, effective, and safely stored medications.
Sustainable Solutions Driving Market Growth
Sustainable solutions are propelling significant growth in the global pharmaceutical secondary packaging market. This trend reflects increasing demand from both consumers and regulatory bodies for eco conscious practices. Pharmaceutical companies are investing in innovative packaging materials and designs that minimize environmental impact throughout the product lifecycle. This includes the adoption of recyclable, biodegradable, and renewable resource based materials for cartons, labels, and inserts. Furthermore, solutions that optimize material usage and reduce waste during manufacturing and distribution are gaining traction. Child resistant features and tamper evident seals are also being integrated with sustainable designs, demonstrating that safety and environmental responsibility are no longer mutually exclusive. This shift towards greener packaging is enhancing brand reputation, meeting stakeholder expectations, and ultimately driving market expansion as companies vie for sustainable leadership.
Serialization and Traceability Imperatives
Pharmaceutical secondary packaging faces immense pressure from serialization and traceability mandates globally. Regulators increasingly demand unique item level identification for every sellable unit, from carton to pallet. This imperative aims to combat counterfeiting, improve drug safety, and streamline recalls by enabling end to end visibility throughout the supply chain. Manufacturers must implement robust systems to print, verify, and aggregate serial numbers at each packaging stage, often involving 2D data matrix codes. Compliance necessitates significant investment in specialized hardware, software, and skilled personnel. These requirements drive innovation in vision systems, robotics, and data management solutions within the secondary packaging market, ensuring compliance while maintaining efficient production and facilitating accurate tracking of pharmaceuticals worldwide.
What are the Key Drivers Shaping the Global Pharmaceutical Secondary Packaging Market
Rising Demand for Prescription Drugs and OTC Medications
The increasing prevalence of chronic diseases globally significantly boosts the consumption of prescription drugs. Conditions like diabetes, cardiovascular diseases, and cancer necessitate long term medication regimens. Concurrently, a growing aging population further elevates demand for both prescription and over the counter medications, as older individuals often require multiple drugs to manage various health issues. This rising consumption directly translates into a greater need for robust and compliant secondary packaging solutions. Pharmaceutical companies must ensure their products are protected during storage and transit, and meet stringent regulatory requirements for child resistance, tamper evidence, and clear labeling. Consequently, the expanding volume of pharmaceuticals sold fuels the growth of the secondary packaging market.
Increased Focus on Patient Safety and Counterfeit Protection
Pharmaceutical companies are intensely prioritizing patient safety and the integrity of their drug supply chains, significantly influencing the secondary packaging market. This heightened focus stems from the critical need to prevent medication errors, protect patients from harmful counterfeit drugs, and ensure product authenticity from manufacturing to dispensing. Regulatory bodies worldwide are also implementing stricter serialization and traceability mandates, compelling manufacturers to adopt advanced packaging solutions. Consequently, there's a strong demand for innovative secondary packaging that incorporates anti-tampering features, unique identifiers, tamper-evident seals, and other security elements. These innovations help verify product authenticity, track drugs throughout distribution, and ultimately safeguard patient well-being, driving substantial growth in specialized packaging technologies.
Growth of Biologics and Specialized Therapeutics Requiring Advanced Packaging
The pharmaceutical industry is experiencing a significant shift towards biologics and other specialized therapeutics. These innovative medicines, often derived from living organisms, are highly sensitive to environmental factors like temperature, light, and oxygen. Consequently, they demand sophisticated packaging solutions beyond traditional methods.
Advanced packaging for these complex drugs includes specialized vials, prefilled syringes, auto-injectors, and custom blister packs. These solutions incorporate enhanced barrier properties, precise dose delivery mechanisms, and robust tamper evidence features. The need for precise temperature control throughout the supply chain, often necessitating cold chain packaging, further fuels this demand. Such specialized containers protect the delicate drug integrity, ensure patient safety, and maintain therapeutic efficacy, driving significant investment and innovation in the secondary packaging market to accommodate these critical requirements.
Global Pharmaceutical Secondary Packaging Market Restraints
Stringent Regulatory Compliance for Packaging Materials and Processes
Stringent regulatory compliance for packaging materials and processes significantly restrains the global pharmaceutical secondary packaging market. Pharmaceutical packaging must adhere to strict guidelines set by bodies like the FDA and EMA to ensure product safety, efficacy, and integrity. This necessitates extensive testing, validation, and documentation for every packaging component and manufacturing step. Companies face high costs associated with obtaining necessary certifications, conducting stability studies, and implementing quality management systems. Furthermore, changes in regulations require costly redesigns and revalidation, creating delays and adding financial burdens. The complexity of navigating diverse international regulations also limits market entry for some manufacturers and slows innovation, as new materials and technologies require lengthy approval processes before widespread adoption. This stringent oversight contributes to higher operational expenses and longer development cycles.
High Capital Investment and Long Qualification Periods for New Packaging Technologies
Adopting novel packaging technologies in pharmaceuticals presents substantial hurdles. Companies face significant upfront costs associated with researching developing and implementing these innovations. This includes expenses for specialized machinery equipment and infrastructure necessary for production. Beyond the financial outlay a protracted qualification period is mandatory. New technologies must undergo rigorous testing and validation to meet stringent regulatory standards for safety efficacy and quality. This involves extensive lab trials stability studies and compatibility assessments with pharmaceutical products. The time invested in this validation process can span several years delaying market entry and return on investment. This combination of high initial capital and extended regulatory scrutiny creates a formidable barrier for pharmaceutical manufacturers considering upgrades or shifts to advanced packaging solutions.
Global Pharmaceutical Secondary Packaging Market Opportunities
Growth in Smart and Serialization-Enabled Secondary Packaging for Enhanced Pharmaceutical Security
The pharmaceutical sector’s escalating battle against counterfeiting and diversion presents a prime opportunity for smart and serialization enabled secondary packaging. This involves integrating unique identifiers like QR codes, RFID, or tamper evident features onto cartons and labels. The primary benefit is vastly enhanced product authenticity and end to to end supply chain traceability.
Companies are significantly investing in these advanced solutions to meet stringent global regulatory mandates for serialization, protect patient safety, and uphold brand integrity. Smart packaging also facilitates real time data capture, enabling more efficient inventory management, precise recalls, and superior supply chain visibility from manufacturer to patient. As the demand for secure and transparent pharmaceutical distribution intensifies globally, the adoption of intelligent secondary packaging is poised for substantial expansion. This growth offers a critical defense against illicit drug trade, ensuring legitimate product delivery and unlocking new avenues for technological integration and market development.
Leveraging Demand for Sustainable and Patient-Centric Pharmaceutical Secondary Packaging Solutions
The pharmaceutical industry faces increasing pressure for environmentally responsible practices and improved patient experiences. A significant opportunity exists in developing and implementing advanced secondary packaging solutions addressing these dual demands. Sustainable packaging innovations, using recycled, recyclable, or biodegradable materials, reducing material usage, and optimizing supply chain waste, resonate with global environmental mandates and corporate sustainability goals. Simultaneously, patient centric designs enhance medication adherence and safety. This involves creating user friendly packaging offering clear dosing instructions, tamper evident features, child resistant yet elder friendly access, and integrated digital tools for tracking and education. For instance, smart packaging can remind patients to take medication or provide real time information. Companies capitalize by offering custom, innovative solutions that protect the drug, empower patients, support therapeutic journeys, and minimize environmental footprint. This strategic focus drives differentiation and value across the global market.
Global Pharmaceutical Secondary Packaging Market Segmentation Analysis
Key Market Segments
By Packaging Type
- •Boxes
- •Labels
- •Blisters
- •Cartons
- •Clamshells
By Material Type
- •Plastic
- •Paperboard
- •Glass
- •Metal
- •Composite
By End Use
- •Pharmaceuticals
- •Biopharmaceuticals
- •Nutraceuticals
- •Medical Devices
By Automation Level
- •Manual
- •Semi-Automatic
- •Fully Automatic
Segment Share By Packaging Type
Share, By Packaging Type, 2025 (%)
- Cartons
- Boxes
- Labels
- Blisters
- Clamshells
www.makdatainsights.com
Why is Cartons the leading segment in the Global Pharmaceutical Secondary Packaging Market?
Cartons hold a dominant position primarily due to their unparalleled versatility, cost effectiveness, and excellent printability. They provide crucial protective housing for primary packaging such as blister packs, bottles, and vials, safeguarding products during transit and storage. Their surface readily accommodates extensive regulatory information, branding, and tamper evident features. Furthermore, cartons are compatible with high speed automated packaging lines, making them an efficient and scalable solution across diverse pharmaceutical product lines, contributing significantly to their widespread adoption.
How do material types influence segment performance in pharmaceutical secondary packaging?
The choice of material type is intrinsically linked to functional requirements and regulatory compliance within the pharmaceutical sector. Paperboard leads this segment, largely propelled by the dominance of cartons, offering sustainable and cost efficient solutions with high print quality. Plastic materials are vital for their flexibility, barrier properties, and lightweight nature, used extensively in various secondary formats. Glass and metal find niche applications where superior barrier properties, chemical inertness, or enhanced product protection are paramount, particularly for sensitive or high value biopharmaceuticals, albeit at a higher cost.
What role does automation level play in shaping the pharmaceutical secondary packaging market?
Automation level is a critical differentiator, reflecting industry trends towards efficiency, precision, and error reduction. Fully automatic systems are increasingly prevalent, especially for high volume production, offering speed, consistency, and reduced labor costs. Semi automatic solutions bridge the gap for medium volume operations, balancing automation with human intervention for specialized tasks. Manual processes, while declining, remain relevant for highly specialized, low volume, or custom packaging requirements. The push for enhanced throughput, improved quality control, and compliance drives significant investment in automated packaging lines across the market.
Global Pharmaceutical Secondary Packaging Market Regulatory and Policy Environment Analysis
The global pharmaceutical secondary packaging market navigates a complex regulatory framework prioritizing patient safety and product integrity. Agencies like the FDA EMA and national health authorities enforce stringent guidelines. A primary focus is anti counterfeiting driven by serialization and track and trace mandates ensuring supply chain security and preventing illicit drugs. Labeling requirements are highly prescriptive demanding clear accurate and accessible information often including multilingual and braille elements. Environmental sustainability is increasingly prominent with policies promoting recyclable biodegradable and eco friendly materials to minimize ecological impact. Material safety compliance for all components is critical preventing contamination. Tamper evident features are also widely regulated enhancing security. Despite harmonization efforts significant regional variations persist compelling manufacturers to meticulously adapt packaging strategies to diverse market demands and evolving legislation. This dynamic environment necessitates continuous vigilance and innovation.
Which Emerging Technologies Are Driving New Trends in the Market?
The global pharmaceutical secondary packaging market is witnessing transformative innovations. Serialization and track trace solutions are paramount, driven by global regulations ensuring product authenticity and supply chain integrity. Emerging technologies include advanced QR codes and tamper evident features integrated directly into secondary packaging. Smart packaging innovations are revolutionizing patient engagement and safety. NFC and RFID sensors enable real time temperature monitoring adherence tracking and authentication verifying product origin and condition. This digital evolution enhances traceability and combats counterfeiting effectively.
Sustainability remains a core innovation driver. Pharmaceutical companies are increasingly adopting eco friendly materials like recycled plastics biodegradable polymers and plant based alternatives for cartons and trays. Advanced digital printing facilitates variable data application and enhances security features. Automation and AI powered systems optimize packaging line efficiency accuracy and defect detection. Innovations also focus on improving child resistance senior friendly designs balancing safety with accessibility for diverse patient populations. These advancements collectively address regulatory demands environmental concerns and patient centric care.
Global Pharmaceutical Secondary Packaging Market Regional Analysis
Global Pharmaceutical Secondary Packaging Market
Trends, by Region
North America Market
Revenue Share, 2025
www.makdatainsights.com
Dominant Region
North America · 35.8% share
North America emerged as a dominant region in the global pharmaceutical secondary packaging market, commanding a substantial 35.8% market share. This leadership is largely attributable to the presence of numerous key pharmaceutical companies and a robust healthcare infrastructure. The region benefits from stringent regulatory frameworks demanding high quality packaging solutions, driving innovation and adoption of advanced technologies like serialization and tamper evident features. Furthermore, increasing pharmaceutical production, a growing demand for specialized packaging for biologics, and a strong focus on patient safety contribute significantly to North America's continued dominance in this crucial sector. The region's commitment to research and development also fuels the expansion of novel packaging materials and designs.
Fastest Growing Region
Asia Pacific · 9.2% CAGR
The Asia Pacific region is poised to be the fastest growing region in the global pharmaceutical secondary packaging market, exhibiting a robust Compound Annual Growth Rate of 9.2% from 2026 to 2035. This accelerated growth is primarily driven by expanding healthcare infrastructure and increasing pharmaceutical production within countries like China and India. A rising prevalence of chronic diseases across the region fuels higher demand for packaged pharmaceuticals. Furthermore, growing disposable incomes contribute to increased healthcare spending. The adoption of advanced packaging solutions to ensure product integrity and comply with evolving regulatory standards also propels market expansion. Local manufacturers are investing in automation and sustainable packaging options, further strengthening the region’s market position.
Impact of Geopolitical and Macroeconomic Factors
Geopolitical shifts directly impact pharmaceutical secondary packaging. Trade wars, protectionist policies, and local content mandates disrupt global supply chains, increasing lead times and costs for specialized materials. Regional conflicts or political instability in key manufacturing hubs for polymers or glass can trigger sudden shortages. Furthermore, heightened focus on supply chain resilience post pandemic encourages regionalization or reshoring of packaging production, altering established distribution networks and potentially increasing local sourcing requirements. Geopolitical realignments also influence regulatory harmonization or divergence, impacting packaging design and labeling.
Macroeconomic factors significantly shape this market. Inflationary pressures on raw materials like plastic resins, paperboard, and inks, combined with rising energy and labor costs, directly escalate packaging expenses. Economic downturns may force pharmaceutical companies to optimize packaging to reduce overall costs, potentially shifting towards more standardized or cost effective solutions. Conversely, robust economic growth, particularly in emerging markets, fuels increased pharmaceutical consumption and, consequently, greater demand for secondary packaging. Currency fluctuations also play a role, impacting import export costs for both packaging materials and finished pharmaceuticals.
Recent Developments
- March 2025
Berry Global and Amcor announced a strategic partnership to develop and commercialize advanced sustainable secondary packaging solutions for the pharmaceutical industry. This collaboration aims to leverage both companies' expertise in recycled content and lightweighting technologies to meet increasing demand for eco-friendly options.
- August 2024
DS Smith introduced a new line of tamper-evident and child-resistant corrugated secondary packaging specifically designed for prescription medications. This product launch directly addresses the growing regulatory requirements and consumer demand for enhanced security features in pharmaceutical packaging.
- November 2024
Gerresheimer acquired a specialized pharmaceutical packaging design firm, bolstering its in-house capabilities for custom secondary packaging solutions. This acquisition allows Gerresheimer to offer more comprehensive end-to-end services, from primary container to final secondary packaging design and manufacturing.
- January 2025
International Paper launched a new bio-based coating for its pharmaceutical secondary packaging board, offering improved moisture barrier properties without compromising recyclability. This strategic initiative targets pharmaceutical companies seeking to reduce their environmental footprint while maintaining product integrity.
Key Players Analysis
Key players like Amcor, Gerresheimer, and WestRock dominate the global pharmaceutical secondary packaging market. They offer diverse solutions including cartons, flexible packaging, and specialized containers, leveraging advanced materials and digital printing. Strategic initiatives involve sustainable packaging, enhanced security features, and smart packaging technologies. Market growth is driven by increasing pharmaceutical production, stringent regulations, and demand for counterfeit protection and patient adherence, pushing innovation in smart and eco-friendly solutions.
List of Key Companies:
- Berry Global
- International Paper
- Crown Holdings
- DS Smith
- Schott
- Neenah
- Amcor
- Gerresheimer
- AptarGroup
- WestRock
- Sonoco Products
- Mondi
Report Scope and Segmentation
| Report Component | Description |
|---|---|
| Market Size (2025) | USD 48.7 Billion |
| Forecast Value (2035) | USD 85.3 Billion |
| CAGR (2026-2035) | 6.2% |
| Base Year | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2035 |
| Segments Covered |
|
| Regional Analysis |
|
Table of Contents:
List of Figures
List of Tables
Table 1: Global Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035
Table 2: Global Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 3: Global Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 4: Global Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Automation Level, 2020-2035
Table 5: Global Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Region, 2020-2035
Table 6: North America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035
Table 7: North America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 8: North America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 9: North America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Automation Level, 2020-2035
Table 10: North America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Country, 2020-2035
Table 11: Europe Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035
Table 12: Europe Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 13: Europe Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 14: Europe Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Automation Level, 2020-2035
Table 15: Europe Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 16: Asia Pacific Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035
Table 17: Asia Pacific Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 18: Asia Pacific Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 19: Asia Pacific Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Automation Level, 2020-2035
Table 20: Asia Pacific Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 21: Latin America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035
Table 22: Latin America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 23: Latin America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 24: Latin America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Automation Level, 2020-2035
Table 25: Latin America Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 26: Middle East & Africa Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035
Table 27: Middle East & Africa Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035
Table 28: Middle East & Africa Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 29: Middle East & Africa Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Automation Level, 2020-2035
Table 30: Middle East & Africa Pharmaceutical Secondary Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035